C-Reactive Protein, Fatal and Nonfatal Coronary Artery Disease, Stroke, and Peripheral Artery Disease in the Prospective EPIC-Norfolk Cohort Study | Zendy

Diederik F. van Wijk | Zendy; S. Matthijs Boekholdt | Zendy; Nicholas J. Wareham | Zendy; Sara AhmadiAbhari | Zendy; John J.P. Kastelein | Zendy; Erik S.G. Stroes | Zendy; KayTee Khaw | Zendy

Open Access

C-Reactive Protein, Fatal and Nonfatal Coronary Artery Disease, Stroke, and Peripheral Artery Disease in the Prospective EPIC-Norfolk Cohort Study

Author(s) -

Diederik F. van Wijk,

S. Matthijs Boekholdt,

Nicholas J. Wareham,

Sara AhmadiAbhari,

John J.P. Kastelein,

Erik S.G. Stroes,

KayTee Khaw

Publication year - 2013

Publication title -

arteriosclerosis thrombosis and vascular biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.007

H-Index - 270

eISSN - 1524-4636

pISSN - 1079-5642

DOI - 10.1161/atvbaha.113.301736

Subject(s) - hazard ratio , medicine , proportional hazards model , confidence interval , coronary artery disease , prospective cohort study , stroke (engine) , c reactive protein , cohort , cardiology , surgery , mechanical engineering , engineering , inflammation

Circulating levels of C-reactive protein (CRP) are associated with an increased risk of coronary artery disease (CAD), stroke, and peripheral artery disease (PAD). Observational and experimental evidence suggest that CRP might differentially predict fatal and nonfatal cardiovascular events. Here, we sought to determine the predictive value of CRP for fatal and nonfatal CAD, stroke, or PAD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research